Bioequivalence Study for Fluticasone Propionate 100 mcg/Salmeterol Xinafoate 50 mcg Inhalation Powder in Healthy Volunteers

The requested reference [980d2739e53262633466feb1181313ef6c55a560] no longer exists in our database. It has been replaced by the current reference: [1f315af592e7ec163c5627740b7f00b248e9c8c0]

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
Bioequivalence study between two inhaler products of fixed dose combination of fluticasone propionate and salmeterol xinafoate inhalation powder
Epistemonikos ID: 7eecaa4901c63b939020830272118a3e57687a48
First added on: Feb 19, 2024